5GLJ image
Entry Detail
PDB ID:
5GLJ
Keywords:
Title:
Crystal Structure of PDZ1 Domain of Human Protein Tyrosine Phosphatase PTP-Bas
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2016-07-11
Release Date:
2016-11-23
Method Details:
Experimental Method:
Resolution:
1.60 Å
R-Value Free:
0.20
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Tyrosine-protein phosphatase non-receptor type 13
Chain IDs:A, B, C, D
Chain Length:96
Number of Molecules:4
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
High-resolution crystal structure of the PDZ1 domain of human protein tyrosine phosphatase PTP-Bas.
Biochem.Biophys.Res.Commun. 478 1205 1210 (2016)
PMID: 27544031 DOI: 10.1016/j.bbrc.2016.08.095

Abstact

Protein tyrosine phosphatase-Basophil (PTP-Bas) is a membrane-associated protein tyrosine phosphatase with five PDZ domains and is involved in apoptosis, tumorigenesis, and insulin signaling. The interaction between PTP-Bas and tandem-PH-domain-containing protein 1/2 (TAPP1/2) plays an essential role in the regulation of insulin signaling. Despite its high sequence homology with the other PDZ domains, only the PDZ1 domain of PTP-Bas showed distinct binding specificity for TAPP1/2. Although the interaction between PTP-Bas PDZ1 and TAPP1/2 is a therapeutic target for diabetes, the structural basis for the interaction has not been elucidated. In the present study, we determined the crystal structure of the PTP-Bas PDZ1 domain at 1.6 Å resolution. In addition, we calculated the structural models of complexes of PTP-Bas PDZ1 and the C-terminal peptides of TAPP1/2 (referred to as TAPP1p/2p). Structural comparison with the PTP-Bas PDZ2/RA-GEF2 peptide complex revealed a structural basis for distinct binding specificity of PTP-Bas PDZ1 for TAPP1p/2p peptides. Our high-resolution crystal structure of PTP-Bas PDZ1 will serve as a useful template for rational structure-based design of novel anti-diabetes therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures